Albert David Q2 Results
- BSE: 524075
- NSE: ALBERTDAVD
- ISIN: INE155C01010
- Sector: Biotechnology & Drugs
BSE
809.20
1.50 (0.19%)
1.50 (0.19%)Volume274.00
Updated: Mon 17 Aug, 2026 | 15:17:28
NSE
805.00
-7.50 (-0.92%)
-7.50 (-0.92%)Volume9.57 K
Updated: Mon 17 Aug, 2026 | 15:29:39
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Albert David Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 26 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 86.93 | 92.99 | 3.97% | 93.88 | -7.41% |
| Depreciation/ Amortization | 2.23 | 2.29 | -6.72% | 1.67 | 33.46% |
| Operating Income | 0.31 | 8.35 | 0.00% | 4.55 | -93.14% |
| Net Income | -3.30 | 32.00 | 0.00% | 18.07 | 0.00% |
| Other Operating Expenses Total | 26.97 | 28.96 | -1.95% | 32.58 | -17.21% |
| Net Income Before Taxes | -2.58 | 35.79 | 0.00% | 25.13 | 0.00% |
| Total Revenue | 87.24 | 101.34 | 23.63% | 98.44 | -11.37% |
| Selling/ General/ Admin Expenses Total | 27.07 | 25.55 | -4.77% | 29.31 | -7.63% |
| Diluted Normalized EPS | -5.79 | 56.07 | 0.00% | 31.67 | 0.00% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.